BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 20394075)

  • 21. Primaquine elicits Foxp3
    Thome R; Casella G; Lotfi N; Ishikawa LWL; Wang Q; Ciric B; Zhang GX; Rostami A
    J Autoimmun; 2020 Nov; 114():102505. PubMed ID: 32595012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitigation of experimental allergic encephalomyelitis by TGF-beta induced Foxp3+ regulatory T lymphocytes through the induction of anergy and infectious tolerance.
    Selvaraj RK; Geiger TL
    J Immunol; 2008 Mar; 180(5):2830-8. PubMed ID: 18292504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination of apoptotic T cell induction and self-peptide administration for therapy of experimental autoimmune encephalomyelitis.
    Kasagi S; Wang D; Zhang P; Zanvit P; Chen H; Zhang D; Li J; Che L; Maruyama T; Nakatsukasa H; Wu R; Jin W; Sun L; Chen W
    EBioMedicine; 2019 Jun; 44():50-59. PubMed ID: 31097410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis.
    Tseveleki V; Tselios T; Kanistras I; Koutsoni O; Karamita M; Vamvakas SS; Apostolopoulos V; Dotsika E; Matsoukas J; Lassmann H; Probert L
    Exp Neurol; 2015 May; 267():254-67. PubMed ID: 25447934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Indefinite mouse heart allograft survival in recipient treated with CD4(+)CD25(+) regulatory T cells with indirect allospecificity and short term immunosuppression.
    Tsang JY; Tanriver Y; Jiang S; Leung E; Ratnasothy K; Lombardi G; Lechler R
    Transpl Immunol; 2009 Sep; 21(4):203-9. PubMed ID: 19446634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD8+ T cells control the TH phenotype of MBP-reactive CD4+ T cells in EAE mice.
    Jiang H; Braunstein NS; Yu B; Winchester R; Chess L
    Proc Natl Acad Sci U S A; 2001 May; 98(11):6301-6. PubMed ID: 11353822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of CD4+ CD25+ regulatory T cell suppressor function by analogs of the selecting peptide.
    Larkin J; Picca CC; Caton AJ
    Eur J Immunol; 2007 Jan; 37(1):139-46. PubMed ID: 17154263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anatomic location and T-cell stimulatory functions of mouse dendritic cell subsets defined by CD4 and CD8 expression.
    McLellan AD; Kapp M; Eggert A; Linden C; Bommhardt U; Bröcker EB; Kämmerer U; Kämpgen E
    Blood; 2002 Mar; 99(6):2084-93. PubMed ID: 11877283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD8+ CD205+ splenic dendritic cells are specialized to induce Foxp3+ regulatory T cells.
    Yamazaki S; Dudziak D; Heidkamp GF; Fiorese C; Bonito AJ; Inaba K; Nussenzweig MC; Steinman RM
    J Immunol; 2008 Nov; 181(10):6923-33. PubMed ID: 18981112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B lymphocytes treated in vitro with antigen coupled to cholera toxin B subunit induce antigen-specific Foxp3(+) regulatory T cells and protect against experimental autoimmune encephalomyelitis.
    Sun JB; Czerkinsky C; Holmgren J
    J Immunol; 2012 Feb; 188(4):1686-97. PubMed ID: 22250081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. De novo-induced self-antigen-specific Foxp3+ regulatory T cells impair the accumulation of inflammatory dendritic cells in draining lymph nodes.
    Alissafi T; Hatzioannou A; Ioannou M; Sparwasser T; Grün JR; Grützkau A; Verginis P
    J Immunol; 2015 Jun; 194(12):5812-24. PubMed ID: 25948818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant T cell receptor molecules can prevent and reverse experimental autoimmune encephalomyelitis: dose effects and involvement of both CD4 and CD8 T cells.
    Kumar V; Coulsell E; Ober B; Hubbard G; Sercarz E; Ward ES
    J Immunol; 1997 Nov; 159(10):5150-6. PubMed ID: 9366445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasmacytoid dendritic cells and type 1 interferon promote peripheral expansion of forkhead box protein 3(+) regulatory T cells specific for the ubiquitous RNA-binding nuclear antigen La/Sjögren's syndrome (SS)-B.
    Pan ZJ; Horton CG; Lawrence C; Farris AD
    Clin Exp Immunol; 2016 Oct; 186(1):18-29. PubMed ID: 27227559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of immunity by a novel population of Qa-1-restricted CD8alphaalpha+TCRalphabeta+ T cells.
    Tang X; Maricic I; Purohit N; Bakamjian B; Reed-Loisel LM; Beeston T; Jensen P; Kumar V
    J Immunol; 2006 Dec; 177(11):7645-55. PubMed ID: 17114434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Curing CNS autoimmune disease with myelin-reactive Foxp3+ Treg.
    Stephens LA; Malpass KH; Anderton SM
    Eur J Immunol; 2009 Apr; 39(4):1108-17. PubMed ID: 19350586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficient and versatile manipulation of the peripheral CD4+ T-cell compartment by antigen targeting to DNGR-1/CLEC9A.
    Joffre OP; Sancho D; Zelenay S; Keller AM; Reis e Sousa C
    Eur J Immunol; 2010 May; 40(5):1255-65. PubMed ID: 20333625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A self-reactive TCR drives the development of Foxp3+ regulatory T cells that prevent autoimmune disease.
    Killebrew JR; Perdue N; Kwan A; Thornton AM; Shevach EM; Campbell DJ
    J Immunol; 2011 Jul; 187(2):861-9. PubMed ID: 21690323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protection against experimental autoimmune encephalomyelitis generated by a recombinant adenovirus vector expressing the V beta 8.2 TCR is disrupted by coadministration with vectors expressing either IL-4 or -10.
    Braciak TA; Pedersen B; Chin J; Hsiao C; Ward ES; Maricic I; Jahng A; Graham FL; Gauldie J; Sercarz EE; Kumar V
    J Immunol; 2003 Jan; 170(2):765-74. PubMed ID: 12517939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CTLA4-Ig modifies dendritic cells from mice with collagen-induced arthritis to increase the CD4+CD25+Foxp3+ regulatory T cell population.
    Ko HJ; Cho ML; Lee SY; Oh HJ; Heo YJ; Moon YM; Kang CM; Kwok SK; Ju JH; Park SH; Park KS; Kim HY
    J Autoimmun; 2010 Mar; 34(2):111-20. PubMed ID: 19665867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Tolerogenic Artificial APC Durably Ameliorates Experimental Autoimmune Encephalomyelitis by Directly and Selectively Modulating Myelin Peptide-Autoreactive CD4
    Wan X; Pei W; Shahzad KA; Zhang L; Song S; Jin X; Wang L; Zhao C; Shen C
    J Immunol; 2018 Aug; 201(4):1194-1210. PubMed ID: 29987163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.